These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12614259)

  • 1. Intraprostatic ethanol chemoablation via transurethral and transperineal injection.
    Plante MK; Gross AL; Kliment J; Kida M; Zvara P
    BJU Int; 2003 Jan; 91(1):94-8. PubMed ID: 12614259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection.
    Zvara P; Karpman E; Stoppacher R; Esenler AC; Plante MK
    Urology; 1999 Sep; 54(3):411-5. PubMed ID: 10475344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic tissue ablation by injection: a literature review.
    Plante MK; Folsom JB; Zvara P
    J Urol; 2004 Jul; 172(1):20-6. PubMed ID: 15201730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
    J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraprostatic injection of 96% ethanol in experimental animal model].
    Martov AG; Pavlov DA; KirpatovskiÄ­ VI; Kudriavtsev IuV
    Urologiia; 2004; (6):21-6. PubMed ID: 15719725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model.
    Levy DA; Cromeens DM; Evans R; Stephens LC; von Eschenbach AC; Pisters LL
    Urology; 1999 Jun; 53(6):1245-51. PubMed ID: 10367863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
    Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
    Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intraprostatic ethanol diffusion using a microporous hollow fiber catheter versus a standard needle.
    King BJ; Plante MK; Kida M; Mann-Gow TK; Odland R; Zvara P
    J Urol; 2012 May; 187(5):1898-902. PubMed ID: 22425049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol injection for the treatment of benign prostatic hyperplasia.
    Kim ED
    Curr Urol Rep; 2002 Aug; 3(4):276-9. PubMed ID: 12149157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion properties of transurethral intraprostatic injection.
    Plante MK; Gross AL; Folsom JB; Zvara P
    BJU Int; 2004 Dec; 94(9):1384-8. PubMed ID: 15610125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue chemoablation.
    Rehman J; Landman J; Sundaram C; Clayman RV
    J Endourol; 2003 Oct; 17(8):647-57. PubMed ID: 14622485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endoscopic injection device: a potential advance in the transurethral treatment of benign prostatic obstruction.
    Ditrolio J; Patel P; Watson RA; Irwin RI
    BJU Int; 2003 Jul; 92(1):143-5. PubMed ID: 12823400
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraprostatic ethanol injection as an alternative therapy in patients with benign prostatic hyperplasia.
    Espinoza AR
    Actas Urol Esp (Engl Ed); 2019 Apr; 43(3):158-164. PubMed ID: 30509604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia: preliminary report.
    Savoca G; De Stefani S; Gattuccio I; Paolinelli D; Stacul F; Belgrano E
    Eur Urol; 2001 Nov; 40(5):504-8. PubMed ID: 11752856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraprostatic injection of alcohol gel for the treatment of benign prostatic hyperplasia: preliminary clinical results.
    Larson BT; Netto N; Huidobro C; de Lima ML; Matheus W; Acevedo C; Larson TR
    ScientificWorldJournal; 2006 Sep; 6():2474-80. PubMed ID: 17619720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of transperineal injection of dehydrated ethanol in the treatment of prostatic obstruction.
    Chiang Po; Chuang YC; Huang CC; Chiang CP
    Urology; 2003 Apr; 61(4):797-801. PubMed ID: 12670568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral enzymatic ablation of the prostate: canine model.
    Harmon WJ; Barrett DM; Qian J; Lauvetz RW; Bostwick DG; Gocken M
    Urology; 1996 Aug; 48(2):229-33. PubMed ID: 8753734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectables in the prostate.
    Saemi AM; Plante MK
    Curr Opin Urol; 2008 Jan; 18(1):28-33. PubMed ID: 18090486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraprostatic ethanol diffusion: comparison of two injection methods using ex vivo human prostates.
    King BJ; Mann-Gow TK; Kida M; Plante MK; Perrapato SD; Zvara P
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):237-41. PubMed ID: 26171881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.